Conference Coverage

U.S. adolescent malignant melanoma nearly halved during 2000-2014


 

REPORTING FROM AAD 18

U.S. incidence rates of malignant melanoma in adolescents fell by nearly half during 2000-2014, based on information from a National Cancer Institute database.

The substantial drop in new cases of malignant melanoma in Americans aged 10-19 years over the most recent 15-year period with data available contrasts with a stable rate among children aged 0-9 years, and a steadily rising rate among adults during the same period, Ryan C. Kelm said at the annual meeting of the American Academy of Dermatology.

Mr. Ryan C. Kelm of Northwestern University, Chicago Mitchel L. Zoler/Frontline Medical News

Mr. Ryan C. Kelm

The findings also confirmed that malignant melanoma is significantly more common in girls, regardless of whether they are aged 0-9 years, or 10-19 years. In addition, girls aged 10-19 years have significantly better 5-year relative survival, compared with boys that age, with rates of 97% and 93%, respectively, said Mr. Kelm, a researcher in the department of dermatology at Northwestern University, Chicago. Relative survival after 5 years among girls and boys aged 0-9 years was 94%. These rates were up from those reported for 2001 in the SEER (Surveillance, Epidemiology, and End Results) Program, when 5-year relative survival was 89% among all children and 92% among all adolescents (J Clin Oncol. 2005 July 20;23[21]:4735-41).

Mr. Kelm and his associates studied U.S. data compiled from 2000 to 2014 by the SEER Program, maintained by the National Cancer Institute. They identified 1,796 patients aged 0-19 years diagnosed with malignant melanoma (218 children and 1,578 adolescents). The overall incidence rate for the entire 15-year period was just over 1 case per million among children and just under 9 cases per million among adolescents. In contrast, the adult U.S. incidence rate estimates for 2018 are pegged at 260 per million among non-Hispanic whites, 40 per million among Hispanics, and 10 per million among black Americans, according to the American Cancer Society.

Pages

Recommended Reading

Mole count predicted melanoma death, especially among men
MDedge Family Medicine
How to best evaluate children’s melanocytic lesions for melanoma
MDedge Family Medicine
Skin cancer procedures up by 35% since 2012
MDedge Family Medicine
California study indicates increased melanoma incidence is real
MDedge Family Medicine
Pembrolizumab, nivolumab linked to 3% rate of neurologic events
MDedge Family Medicine
Lithium may reduce melanoma risk
MDedge Family Medicine
Melanoma incidence increased in older non-Hispanic whites
MDedge Family Medicine
Dermoscopy will help diagnose pediatric melanomas
MDedge Family Medicine
VIDEO: U.S. melanoma incidence hits all-time high
MDedge Family Medicine
When to worry about congenital melanocytic nevi
MDedge Family Medicine